1. Home
  2. TRVG vs IVA Comparison

TRVG vs IVA Comparison

Compare TRVG & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVG
  • IVA
  • Stock Information
  • Founded
  • TRVG 2005
  • IVA 2011
  • Country
  • TRVG Germany
  • IVA France
  • Employees
  • TRVG N/A
  • IVA N/A
  • Industry
  • TRVG EDP Services
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRVG Technology
  • IVA Health Care
  • Exchange
  • TRVG Nasdaq
  • IVA Nasdaq
  • Market Cap
  • TRVG 118.2M
  • IVA 117.3M
  • IPO Year
  • TRVG N/A
  • IVA 2020
  • Fundamental
  • Price
  • TRVG $1.66
  • IVA $2.72
  • Analyst Decision
  • TRVG Buy
  • IVA Strong Buy
  • Analyst Count
  • TRVG 4
  • IVA 4
  • Target Price
  • TRVG $2.55
  • IVA $14.00
  • AVG Volume (30 Days)
  • TRVG 47.3K
  • IVA 40.6K
  • Earning Date
  • TRVG 11-05-2024
  • IVA 09-25-2024
  • Dividend Yield
  • TRVG N/A
  • IVA N/A
  • EPS Growth
  • TRVG N/A
  • IVA N/A
  • EPS
  • TRVG N/A
  • IVA N/A
  • Revenue
  • TRVG $510,563,239.00
  • IVA $20,652,523.00
  • Revenue This Year
  • TRVG N/A
  • IVA N/A
  • Revenue Next Year
  • TRVG $5.96
  • IVA $361.78
  • P/E Ratio
  • TRVG N/A
  • IVA N/A
  • Revenue Growth
  • TRVG N/A
  • IVA N/A
  • 52 Week Low
  • TRVG $1.60
  • IVA $1.53
  • 52 Week High
  • TRVG $3.29
  • IVA $4.75
  • Technical
  • Relative Strength Index (RSI)
  • TRVG 44.55
  • IVA 58.08
  • Support Level
  • TRVG $1.66
  • IVA $2.52
  • Resistance Level
  • TRVG $1.69
  • IVA $2.85
  • Average True Range (ATR)
  • TRVG 0.05
  • IVA 0.13
  • MACD
  • TRVG 0.00
  • IVA -0.02
  • Stochastic Oscillator
  • TRVG 22.94
  • IVA 61.19

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: